Seattle Genetics Announces ADCETRIS (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin…
Seattle Genetics announced that its collaborator, Takeda Pharmaceutical Company Limited (Takeda), has received approval from the Japanese Ministry of Health, Labour and Welfare for…
Read More...
Read More...
